References
- Gass JD. Bio microscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol. 1994;118:285–298.
- Jabs DA, Nussenblatt RB, Rosenbaum JT, et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
- Macular Photocoagulation Study Group Argon laser photocoagulation for neovascular maculopathy: five year results from randomized clinical trials. Arch Ophthalmol. 1991;109:1109–1111.
- Treatment of Age-related macular degeneration with Photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol. 1999;117:1329–1345.
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of randomized clinical trial inkling lesions with occult with no classic choroidal neovascularization – verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001;131:541–560.
- Menezo V, Cuthbertson F, Downes SM. Positive response to intravitreal Ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy. Retina. 2010 Oct;30(9):1400–1404.
- Mansour AM, Mackensen F, Arevalo JF, et al. Intravitreal Bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol. 2008;146:410–416.
- Mehta S, Hariharan L, Ho AC, Kempen JH. Peripapillary choroidal neovascularization in pars planitis. J Ophthalmic Inflamm Infect. 2013;3:13.
- Spaide RF, Laud K, Fine HF, et al. Intravitreal Bevacizumab treatment of choroidal neovascularization secondary to age related macular degeneration. Retina. 2006;26:383–390.
- Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ. The use of corticosteroids for choroidal neovascularization in young patients. Eye. 1998;12:266–272.
- Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology. 2003;110:1517–1525.
- Kwak N, Okamoto N, Wood JM, Campochiaro PA. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000;41:3158–3164.
- Kramer M, Axer-Siegel R, Jaouni T, et al. Bevacizumab for choroidal neovascularization related to inflammatory diseases. Retina. 2010;30:938–944.
- Mansour AM, Arevalo JF, Ziemssen F, et al. Long-term visual outcomes of intravitreal Bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol. 2009;148(2):310e312–316e312.
- Fine HF, Zhitomirsky I, Freund KB, et al. Bevacizumab (avastin) and Ranibizumab (Lucentis) for choroidal neovascularization in multifocal choroiditis. Retina. 2009 Jan;29(1):8–12.
- Mansour AM, Arevalo JF, Fardeau C, et al. Three-year visual and anatomic results of administrating intravitreal Bevacizumab in inflammatory ocular neovascularization. Can J Ophthalmol. 2012;47:269–274.
- Arevalo JF, Adan A, Berrocal MH, et al. Intravitreal Bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months. Retina. 2011;31(2):353–363.
- Baxter SL, Pistilli M, Pujari SS, et al. Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol. 2013 Sep;156(3):468–477.